A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs
Ashley
A
D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000941:ethics* / Q000331:legislation & jurisprudence; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006297:Health Services Accessibility / Q000941:ethics* / Q000331:legislation & jurisprudence; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence; D007880:Legislation, Drug / Q000941:ethics*; D016365:Liability, Legal; D019452:Terminally Ill / Q000331:legislation & jurisprudence*; D013792:Thalidomide / Q000009:adverse effects; D035703:Therapies, Investigational / Q000941:ethics*; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D015507:Drugs, Investigational; D013792:Thalidomide